SAŽETAK

Osnovni klinički problem u terapiji parodontopatije predstavlja rekonstrukcija infrakoštanih defekata nastalih u toku hroničnog infl amatornog procesa. Cilj ovog istraživanja bio je da se uporede primene dva koštana substituenta i proceni uspešnost regeneracije dubokih infrakoštanih defekata parodoncijuma, posle primene novog materijala bifaznog kalcijum fosfata/poli-dl-laktid-koglikolida-"Biohapel"-a.
U istraživanje je uključeno 12 Ključne reči: infrakoštani defekti, koštani zamenici, parodontalni džep, nivo pripojnog epitela radentium from a bone substituent based on a hydroxyapatite coated with a polymer, "Biohapel, " in comparison to a commonly used synthetic preparation of β tricalcium phosphate (Cerasorb®).
MATERIALS AND METHODS
Here, we used a controlled and blinded trial based on a split mouth method. Our study compared two implant materials, including Biohapel in granules of 50-650 nanometres and ßTCP (Cerasorb®, Curasan, Germany) in granules of 63-250 micrometres. This research was approved by the Ethical Committee of the Faculty of Dentistry in Belgrade (number 123/2).
The clinical study included patients without systemic diseases and allergies, patients who haven't used antibiotics for at least 6 months prior to the start of the study, and non-smokers. The study excluded patients with terminal illness, pregnant women and nursing mothers and patients with acute inflammation of the paradentium. The study included 12 patients with bilateral infrabony defects of the paradentium at least 4 mm deep on the side teeth of the lower jaw. Each participant signed a consent form to be involved in the study.
Two weeks before surgery all patients received a basic treatment for the affected paradentium consisting of instruction about maintaining adequate oral hygiene, removing all soft and firm deposits from the teeth, correction of bad fillings and other iatrogenic factors.
The surgical procedure began with the local application of lidocaine and epinephrine in a ratio of 1:100, 000. After an intrasulcular incision, the full thickness of the cheek flap and lingual flap was lifted. After treating the periodontal pockets by debriding the granulation tissue and surface of the root, random infrabony defects from one side of the lower jaw in the region of first molars and first and second premolars on the mesial and distal side were reconstructed by applying Biohapel (experimental group n=72). The other side of the lower jaw in a region of equivalent teeth was reconstructed using β tricalcium phosphate (Cerasorb®) (control group, n=72). The implanted material was firmly packed into intra-bony defects with a sterile amalgam rammer. Finally, the mucoperiosteal flaps were repositioned and sutured primarily with single interdental sutures (Ethicon ® , Mersilk 4-0, USA). The condition of the paradentium was evaluated using the depth of the periodontal pockets (DPP) and the level of the junctional epithelium (LJE) as clinical parameters. All parameters of the affected paradentium were verified before surgical treatment and 6 months after surgery. Measurements were performed using a millimetre graduated pigtail explorer (PCP-UNC 15, Hu-Friedy, Leimen, Germany), and the obtained values were recorded in millimetres. Patients had a follow-up visit on the first day after surgery and again on the seventh day post-surgery to have their stitches. Subsequently, follow-up visits occurred
INTRODUCTION
Parodontopathy represents a multifactorial illness caused by periodontal pathogenic microorganisms, and its course and outcome are determined by the genetic predisposition and immunological response of the patient 1 . The aetiology of parodontopathy is well-known, but the treatment of this disease is very complex and dependent on many factors (1, 2). The chronic inflammatory processes observed in parodontopathy can lead to extensive damage of the periodontium. One of the most complicated symptoms of parodontopathy is the development of infrabony defects because they are extremely difficult to treat. Reconstruction of these defects is exceptionally demanding and their presence contributes to an unfavourable illness prognosis (1) .
Regeneration of destroyed tissues within in paradentium (restitutio ad integrum) represents the main objective for parodontopathy treatment. A standard procedure in the treatment of periodontal pockets is an MWRO (modified flap operation), but it shows little success in eliminating infrabony periodontal defects; thus, to enhance the regeneration of periodontal tissues, we have assessed various bone substituents (3, 4) . A novel concept for the regeneration of periodontal tissues is based on the application of biomaterials that enable regeneration of the paradentium with varied efficiency (5) .
Bone tissue has the smallest regenerative potential when compared with the surrounding tissues of the paradentium, but its proper functioning is of great importance. In periodontal surgery, various materials of different origins, including biological and synthetic, have been used for implantation into bony defects in an attempt to improve the regeneration and reparation of periodontal tissue (4).
The materials used for implantation need to have particular features, including biological compatibility, be easy to use, cause minimum postoperative complications and be financially acceptable for the patient. The basic principle behind using bone substituents is the assumption that the material has an osteogenic, osteoconductive and osteoinductive potential. This material is also expected to be resorptive and completely replaced by the newly formed bone (6) .
Calcium phosphate is the main constituent of bone, and crystal hydroxyapatite (HAP) provides mechanical firmness to the bone. HAP, which is identical to the HAP in bones, can be obtained synthetically from biphasic calcium phosphate to produce a HAP that is mixed with tricalcium phosphate and a polymer component of poly lactide-coglycolide (Biohapel) (7). Immediately after implantation, the polymer component (poly lactide-co-glycolide) of Biohapel shows an exceptional ability at adhering to osteoblasts, enhancing its osteogenic potential (8) . When in contact with a vital bone, the material is resorbed within several months and is replaced with a newly formed bone without causing local or systemic toxicity (9) .
The objective of our research was to analyse the degree of bone regeneration in infrabony defects of the pa-frabony periodontal defects six or more months after the application of various bone substituents (3, 10, 11, 12, 13) . Lukovic and associates conducted a clinical study that showed Cerasorb and Bioss have similar efficacies as a treatment for deep infrabony pockets (14) . Saini and associates found limited improvement using beta tricalcium phosphate to treat infrabony defects and determined that beta tricalcium phosphate in combination with biologically active factors provides a significantly better result (15) . Jansen and associates showed that the main shortcoming of beta tricalcium phosphate is its fast resorption and that priority in the treatment of bony defects should be given to autogenous transplants (16) . Elyan and associates showed that application of the nanocrystal hydroxyapatite as a treatment for infrabony once a month up for six months to follow the degree of tissue healing after the surgery. Data were analysed using the statistics package SPSS (version 18.0). The results are presented as the average ± standard deviation (A+SD). A value of p<0.05 was considered statistically significant.
RESULTS
After treatment, the results obtained from both groups showed a statistically significant reduction in the examined parameters (Table 1) . Analysis of the depth of the periodontal pocket and the level of junctional epithelium six months after the surgery showed that there was a statistically significant difference after the application of the two tested materials (Figures 1 and 2 ). There was a statistically significant reduction in the DPP and LJE of the Biohapel group when compared with the Cerasorb group ( Table 2) . No complications were recorded during the postoperative period. Abbreviations: DPP -depth of a periodontal pocket, LJE -level of junctional epithelium, A±SD -average ± standard deviation, p -statistical signifi cance
DISCUSSION
Our results show that application of the bone substituent Biohapel is a significantly improved treatment for deep infrabony defects of the paradentium whencompared with synthetic β tricalcium phosphate. Numerous studies have previously shown a significant reduction in the depth of in- Mann-Whitney U test p =0,020
Abbreviations: n -number of infrabony periodontal defects, A±SD -average ± standard deviation, ;p -statistical signifi cance, DPP -depth of a periodontal pocket, LJE -level of junctional epithelium defects led to a significant reduction in the depth of infrabony defects and had a stimulating effect on angiogenesis and osteogenesis. This same study also showed that the nanocrystal hydroxyapatite easily adhered to the fibroblasts and osteoblasts of the periodontal ligament (17) . Porosity, surface structure, particle size and chemical features have are key characteristics that dictate the regenerative and osteoconductive potential of bone substituents (18) . Thus, the greater treatment efficacy of Biohapel that we observed was most likely a consequence of the specific features of the material. Biohapel is the first nanocrystal material coated with a polymer component that has been used for the treatment of deep defects of paradentium, and its polymer component strongly adheres to the surrounding cells that are involved in tissue regeneration. Therefore, the size of the Biohapel particles and the PLGA polymer component provide this newly synthesised material with advantageous features. Additional research is needed to determine the long-term efficacy of Biohapel. In addition, a histological analysis of human preparations could determine any distinct characteristics of Biohapel as a treatment for infrabony periodontal defects. Our study undeniably shows that the application of biphasic calcium phosphate/poly DL-lactide-co-glycolide produces significant levels of bone regeneration and is a viable treatment option for infrabony defects of the paradentium.
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